Factors associated with hemoglobin variation in women submitted to hemodialysis
Keywords:Chronic kidney disease; Anemia; Hemodialysis.
To evaluate the factors associated with the decline in hemoglobin in patients with CKD. This is a cross-sectional study, conducted with women undergoing hemodialysis, except for those with hemolytic diseases. The collection of biochemical and anthropometric data was carried out from the electronic medical records of the patients included in the research. 80% of the women were adults and the most prevalent chronic condition was Systemic Arterial Hypertension (75.65%). It was possible to verify that all the categories analyzed presented an average hemoglobin value below 12g /dL, indicating anemia as a problem in effect in the studied public. The factors that showed a statistically significant association with the lowest hemoglobin levels were: Hypertension, Diabetes mellitus and the shortest time on hemodialysis. The presence of other conditions in patients with CKD, such as diabetes, hypertension and shorter hemodialysis time, contribute to greater impairment of hemoglobin levels.
Bragman R. (2009). Anemia na Doença Renal Crônica. Braz J. Nephrol., 31 (1 suppl 1), 36-41. https://www.bjnephrology.org/en/article/anemia-na-doenca-renal-cronica/
Bowry, S. K., & Gatti, E. (2011). Impact of Hemodialysis Therapy on Anemia of Chronic Kidney Disease: The Potential Mechanisms. Blood Purification, 32(3), 210-219. doi:10.1159/000329573
El-Achkar, T. M., Ohmit, S. E., Mccullough, P. A., Crook, E. D., Brown, W. W., Grimm, R., Flack, J. M. (2005). Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. Kidney International, 67(4), 1483-1488. doi:10.1111/j.1523-1755.2005.00226.x
Gargiulo, R., Suhail, F., & Lerma, E. V. (2015). Hypertension and chronic kidney disease. Disease-a-Month, 61(9), 387-395. doi:10.1016/j.disamonth.2015.07.003
Hazin, M. A. (2020). Anemia in chronic kidney disease. Revista Da Associação Médica Brasileira, 66(Suppl 1). doi:10.1590/1806-9282.66.s1.55
Kruse, A., Uehlinger, D. E., Gotch, F., Kotanko, P., & Levin, N. W. (2008). Red Blood Cell Lifespan, Erythropoiesis and Hemoglobin Control. Hemodialysis - From Basic Research to Clinical Trials Contributions to Nephrology, 247-254. doi:10.1159/000130698
Maiese, K. (2015). Erythropoietin and diabetes mellitus. World Journal of Diabetes, 6(14), 1259. doi:10.4239/wjd.v6.i14.1259
Penteado, B.A.., Lima, W.F., Milagres, C.S. (2017). Etiologia de anemia em pacientes renais crônicos em tratamento hemodialítico. Rev. Cien. FHO, v. 5, n. 1, p. 18-23.
Prestes, F.C., et al (2011). Percepção dos trabalhadores de enfermagem sobre a dinâmica do trabalho e os pacientes em um serviço de hemodiálise. Text. Cont. Enferm., v. 20, n. 1, p. 25-32.
Ribeiro, W.A., Jorge B.O., Queiroz, R.S. (2020). Repercussões da hemodiálise no paciente com doença renal crônica. Revista Pró-UniverSUS, v. 11, n. 1, p. 88-97.
Rosa, K.R.., Loures, M.C. (2013). Qualidade de vida de idosos em hemodiálise. EVS, v. 40, n. 4, p. 419-446.
Santos, N.C., et al. (2020). O papel do Enfermeiro na anemia associada à doença renal crônica. Research Society and Development, v. 9, n. 8, p. 1-16.
Shaikh, H.., Aeddula, N.R. (2020). Anemia Of Chronic Renal Disease. https://www.ncbi.nlm.nih.gov/books/NBK539871/
Sociedade Brasileira de Nefrologia (2017). Tratamento Hemodialítico. https://sbn.org.br
Stauffer, M. E., & Fan, T. (2014). Prevalence of Anemia in Chronic Kidney Disease in the United States. PLoS ONE, 9(1). doi:10.1371/journal.pone.0084943
Symeonidis, A., Kouraklis-Symeonidis, A., Psiroyiannis, A., Leotsinidis, M., Kyriazopoulou, V., Vassilakos, P., Zoumbos, N. (2005). Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin-dependent diabetes mellitus. Annals of Hematology, 85(2), 79-85. doi:10.1007/s00277-005-1102-9
Ulijaszek, S. J. (2003). Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Pp. 252.
Viazzi, F., Leoncini, G., & Pontremoli, R. (2013). Antihypertensive Treatment and Renal Protection: The role of drugs inhibiting the renin-angiotensin-aldosterone system. High Blood Pressure & Cardiovascular Prevention, 20(4), 273-282. doi:10.1007/s40292-013-0027-y
Wish, J., Aronoff, G., Bacon, B., Brugnara, C., Eckardt, K. & Ganz, T., Wood, J. (2018). Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell? American Journal of Nephrology, 47(2), 72-83. doi:10.1159/000486968
World Health Organization (WHO) (2015). The global prevalence of anaemia in 2011. Geneva: World Health Organization. pag. 43.
World Health Organization (WHO). Obesity - Preventing and managing the global epidemic: Report of a WHO consultation. Geneva: World Health Organization, 2000, pag. 268.
How to Cite
Copyright (c) 2021 Danielle Alice Vieira da Silva; Lidyane Cerqueira de Araujo Silva; Ícaro Carlos Oliveira de Andrade; Ayná Santos de Lima; João Paulo da Silva Lima; Ana Debora Santos de Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.